Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Pseudomonas Aeruginosa (P. aeruginosa)
100%
Cystic Fibrosis
100%
Inflammation Markers
100%
Azithromycin
100%
Systemic Markers
100%
Calprotectin
71%
High-sensitivity C-reactive Protein (hs-CRP)
57%
Serum Amyloid A
57%
Absolute Neutrophil Count
42%
Forced Expiratory Volume in 1 Second (FEV1)
28%
Granulocyte Colony-stimulating Factor (G-CSF)
28%
Myeloperoxidase
28%
Change in Weight
28%
Lung Function
14%
Treatment Effect
14%
Double-blind Trial
14%
Placebo
14%
Placebo Groups
14%
Mechanism of Action
14%
Initiating Treatment
14%
Interleukin-6
14%
Absolute Change
14%
Relative Change
14%
Neutrophil Count
14%
Inflammatory Markers
14%
Days of Treatment
14%
WBC Count
14%
Trial Registries
14%
Intracellular Adhesion molecule-1
14%
FEV1% Predicted
14%
WBC Differential
14%
Immunomodulatory Drugs (IMiDs)
14%
Serum Inflammatory Markers
14%
Protein Amyloid
14%
Systemic Inflammatory Markers
14%
Biochemistry, Genetics and Molecular Biology
Cystic Fibrosis
100%
Pseudomonas aeruginosa
100%
Calgranulin
100%
Serum Amyloid A
80%
C-Reactive Protein
60%
Absolute Neutrophil Count
60%
Granulocyte Colony-Stimulating Factor
40%
Myeloperoxidase
40%
Randomized Controlled Trial
20%
Interleukin 6
20%
Leukocyte Count
20%
Neutrophil Count
20%
Leukocyte Differential Count
20%
Cell Adhesion Proteins
20%
Immunology and Microbiology
Neutrophil Count
100%
Pseudomonas aeruginosa
100%
Serum Amyloid A
100%
Inflammation
100%
C-Reactive Protein
75%
Granulocyte Colony-Stimulating Factor
50%
Myeloperoxidase
50%
Interleukin 6
25%
Leukocyte Count
25%
Cell Adhesion Proteins
25%
Leukocyte Differential Count
25%
Lung
25%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Pseudomonas aeruginosa
100%
Azithromycin
100%
Cystic Fibrosis
100%
Calgranulin
71%
Serum Amyloid A
57%
C Reactive Protein
42%
Placebo
28%
Myeloperoxidase
28%
Granulocyte Colony Stimulating Factor
28%
Randomized Controlled Trial
14%
Interleukin 6
14%
Cell Adhesion Proteins
14%